Natalie Flanagan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Natalie Flanagan has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Eric Sterner
Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute , Frederick, Maryland 21702, United States
1 shared publication- Jeffrey C. Gildersleeve
Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA
1 shared publication
Latest Publications
- Open Access
- 25 May 2016
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 11 (7) , 1773-1783
Perspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database
Antibodies are used extensively for a wide range of basic research and clinical applications. While an abundant and diverse collection of antibodies to protein antigens have been developed, good monoclonal antibodies to carbohydrates are much less common. Moreover, it can be difficult to determine if a particular antibody has the appropriate specificity, which antibody is best suited for a given application, and where to obtain that antibody. Herein, we provide an overview of the current state of the field, discuss challenges for selecting and using antiglycan antibodies, and summarize deficiencies in the existing repertoire of antiglycan antibodies. This perspective was enabled by collecting information from publications, databases, and commercial entities and assembling it into a single database, referred to as the Database of Anti-Glycan Reagents (DAGR). DAGR is a publicly available, comprehensive resource for anticarbohydrate antibodies, their applications, availability, and quality.
- 25 May 2016
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 11 (7) , 1773-1783
Open AccessPerspectives on Anti-Glycan Antibodies Gleaned from Development of a Community Resource Database
Antibodies are used extensively for a wide range of basic research and clinical applications. While an abundant and diverse collection of antibodies to protein antigens have been developed, good monoclonal antibodies to carbohydrates are much less common. Moreover, it can be difficult to determine if a particular antibody has the appropriate specificity, which antibody is best suited for a given application, and where to obtain that antibody. Herein, we provide an overview of the current state of the field, discuss challenges for selecting and using antiglycan antibodies, and summarize deficiencies in the existing repertoire of antiglycan antibodies. This perspective was enabled by collecting information from publications, databases, and commercial entities and assembling it into a single database, referred to as the Database of Anti-Glycan Reagents (DAGR). DAGR is a publicly available, comprehensive resource for anticarbohydrate antibodies, their applications, availability, and quality.